Showing results (161-170 of 530) with videos related to
Sort By:
Pageof 53
Molecular Biology of the Cell|February 3, 2021
Predicting cell health phenotypes using image-based morphology profilingGregory P Way, Maria Kost-Alimova, Tsukasa Shibue, et al.Cancer Research|March 5, 2004
A genetically defined model for human ovarian cancerJinsong Liu, Gong Yang, Jennifer A Thompson-Lanza, et al.Journal of Virology|December 26, 2014
Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigensElizabeth A White, Rebecca E Kramer, Justin H Hwang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancerEvan Y Yu, George Wilding, Edwin Posadas, et al.Clinical Genitourinary Cancer|December 24, 2013
Nonresponse to neoadjuvant chemotherapy for muscle-invasive urothelial cell carcinoma of the bladderMatthew Mossanen, Franklin Lee, Heather Cheng, et al.Science Signaling|July 23, 2009
SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasisHailing Cheng, Pixu Liu, Zhigang C Wang, et al.Nature|July 25, 2006
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9Andrei V Krivtsov, David Twomey, Zhaohui Feng, et al.Plos One|September 30, 2020
Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancerAlexander S Carlson, Rigo I Acevedo, Daniel M Lim, et al.The Canadian Journal of Urology|April 20, 2024
Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathwaysDavid E Crawford, David Albala, Marc B Garnick, et al.Cancer Research|March 23, 2019
Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian CancersColles Price, Stanley Gill, Zandra V Ho, et al.Pageof 53